Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA)

References

• Villegas MV, Hartstein AI. Acinetobacter out breaks, 1977–2000. Infect Control Hosp Epidemiol. 2003;24:284–95.
   PubMed Web of Science ®Google Scholar
• Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73:355–63.
   PubMed Web of Science ®Google Scholar
• Anton YP, David CH. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362:1804–13.
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826–36.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Woodford N. The lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14:413–20.
   PubMed Web of Science ®Google Scholar
• Shin JA, Chang YS, Kim HJ, Kim SK, Chang J, Ahn CM, et al. Clinical outcomes of tigecycline in thetreatment of multidrug-resistant Acinetobacter baumannii infection. Yonsei Med J. 2012;53(5):974–84.
   PubMed Web of Science ®Google Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42:692–9.
   PubMed Web of Science ®Google Scholar
• Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis. 2006;42:657–68.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 11^th informational supplement. Wayne: NCCLS; 2001. p.M100–11.
   Google Scholar
• Gordon C, Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically Ill patients. J Clin Microbiol. 2009;47:2249–51.
   PubMed Web of Science ®Google Scholar
• Delphine G, Laurent P, Patrice N. Value of the modified hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol. 2012;50(2):477–9.
   PubMed Web of Science ®Google Scholar
• Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, et al. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother. 2005;49(7):2941–8.
   PubMed Web of Science ®Google Scholar
• Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(10):4174–9.
   PubMed Web of Science ®Google Scholar
• Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M- type)and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian Hospitals. J Antimicrob Chemother. 2006;57(5):975–8.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351–3.
   PubMed Web of Science ®Google Scholar
• Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta lactamases. J Antimicrob Chemother. 2007;59(2):321–2.
   PubMed Web of Science ®Google Scholar
• Moubareck C, Brémont S, Conroy MC, Courvalin Pand Lambert T. GES-11, a novel integron- associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(8):3579–81.
   PubMed Web of Science ®Google Scholar
• Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, et al. Prevalence and diversity of carbapenemases among imipenem nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis. 2010;68(4):432–8.
   PubMed Web of Science ®Google Scholar
• Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, et al. OXA-and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20(5):410–5.
   PubMed Web of Science ®Google Scholar
• Segal H, Garny S, Elisha BG. Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett. 2005;243:425–9.
   PubMed Web of Science ®Google Scholar
• Mussi MA, Limansky SA, Viale AM. Acquisition of Resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel. Antimicrob Agents Chemother. 2005;49(4):1432–40.
   PubMed Web of Science ®Google Scholar
• Roger LW, David SB, Madhavi M, John AB. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996;40:1914–8.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.
   PubMed Web of Science ®Google Scholar
• Wybo I, Blommaert L, De Beer T, Soetens O, De Regt J, Lacor P, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian University Hospital after transfer of patients from Greece. J Hosp Infect. 2007;67:374–80.
   PubMed Web of Science ®Google Scholar
• Song W, Lee J, Kim TK, Park MJ, Kim HS, Kim JS. Modified CHROMagar Acinetobacter medium for direct detection of multidrug-resistant Acinetobacter strains in nasal and rectal swab samples. Ann Lab Med. 2013;33(3):193–5.
   PubMed Web of Science ®Google Scholar
• Mugnier P, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35–40.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7–15.
   PubMed Web of Science ®Google Scholar